pharmaphorum22h
Novartis hits back at Entresto selection on Medicare list
Novartis has responded to the inclusion of its heart failure blockbuster Entresto on the list of the first 10 drugs that will be subject to Medicare pricing negotiations, claiming that the move ...
BioPharma Dive2d
FDA broadens use of Novartis’ radiopharma drug Pluvicto
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
Novartis9d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Basel, March 20, 2025 – Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G) ...
Hosted on MSN1mon
Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds
We recently published a list of 12 Best Global Stocks ... front of a laboratory sample of healthcare products. Number of Hedge Fund Holders: 33 Novartis AG (NYSE:NVS) manufactures pharmaceutical ...